# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-031374
Filing Date
2025-08-15
Accepted
2025-08-14 21:37:47
Documents
44
Period of Report
2025-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20053945_8k.htm iXBRL | 8-K | 41703
2 | EXHIBIT 1.1 | ef20053945_ex1-1.htm | EX-1.1 | 250463
3 | EXHIBIT 5.1 | ef20053945_ex5-1.htm | EX-5.1 | 16810
4 | EXHIBIT 99.1 | ef20053945_ex99-1.htm | EX-99.1 | 55498
5 | EXHIBIT 99.2 | ef20053945_ex99-2.htm | EX-99.2 | 12174
9 |  | ef20053945_ex99-1slide1.jpg | GRAPHIC | 156996
10 |  | ef20053945_ex99-1slide2.jpg | GRAPHIC | 430856
11 |  | ef20053945_ex99-1slide3.jpg | GRAPHIC | 153636
12 |  | ef20053945_ex99-1slide4.jpg | GRAPHIC | 152586
13 |  | ef20053945_ex99-1slide5.jpg | GRAPHIC | 174477
14 |  | ef20053945_ex99-1slide6.jpg | GRAPHIC | 147992
15 |  | ef20053945_ex99-1slide7.jpg | GRAPHIC | 133690
16 |  | ef20053945_ex99-1slide8.jpg | GRAPHIC | 146160
17 |  | ef20053945_ex99-1slide9.jpg | GRAPHIC | 63232
18 |  | ef20053945_ex99-1slide10.jpg | GRAPHIC | 237641
19 |  | ef20053945_ex99-1slide11.jpg | GRAPHIC | 65542
20 |  | ef20053945_ex99-1slide12.jpg | GRAPHIC | 170442
21 |  | ef20053945_ex99-1slide13.jpg | GRAPHIC | 143587
22 |  | ef20053945_ex99-1slide14.jpg | GRAPHIC | 182600
23 |  | ef20053945_ex99-1slide15.jpg | GRAPHIC | 143489
24 |  | ef20053945_ex99-1slide16.jpg | GRAPHIC | 178520
25 |  | ef20053945_ex99-1slide17.jpg | GRAPHIC | 177820
26 |  | ef20053945_ex99-1slide18.jpg | GRAPHIC | 157309
27 |  | ef20053945_ex99-1slide19.jpg | GRAPHIC | 108360
28 |  | ef20053945_ex99-1slide20.jpg | GRAPHIC | 169344
29 |  | ef20053945_ex99-1slide21.jpg | GRAPHIC | 47694
30 |  | ef20053945_ex99-1slide22.jpg | GRAPHIC | 167333
31 |  | ef20053945_ex99-1slide23.jpg | GRAPHIC | 195113
32 |  | ef20053945_ex99-1slide24.jpg | GRAPHIC | 200343
33 |  | ef20053945_ex99-1slide25.jpg | GRAPHIC | 90838
34 |  | ef20053945_ex99-1slide26.jpg | GRAPHIC | 44428
35 |  | image0.jpg | GRAPHIC | 4532
36 |  | image00001.jpg | GRAPHIC | 9305
| Complete submission text file | 0001140361-25-031374.txt |  | 6176752

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | aqst-20250814.xsd | EX-101.SCH | 3868
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | aqst-20250814_lab.xml | EX-101.LAB | 21966
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | aqst-20250814_pre.xml | EX-101.PRE | 16046
47 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20053945_8k_htm.xml | XML | 4067

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251222221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)